Clinical Trials Logo

Clinical Trial Summary

The primary hypothesis for this study is that Myostatin and FHL-1 are important in the development of ICUAP and that changes in activity levels of muscle will modify the levels of expression and activity of these proteins.


Clinical Trial Description

ICUAP is an increasingly recognised clinical problem associated with significant morbidity and mortality. However the pathogenesis of the diseae is poorly understood and as yet no treatment exists. We believe that both myostatin and FHL-1 will be important in the development of this disease. This is based recent research and that both these proteins are likely to be regulated by sepsis and immobility (two major risk factors for ICUAP. There is evidence from invitro work that the two are likely to interact. We have designed an interventional trial to investigate the above hypothesis. Patients admitted to ICU and at risk of developing muscle wasting will be selected and receive electrical muscle stimulation of the quadriceps muscle for 1 week. Physiological measurements of peripheral and respiratory muscle strength and quadriceps size will be made pre and post intervention. And muscle biopsies, blood and urine collected from both legs pre and post intervention. The relevant molecular pathways can then be examined. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01321320
Study type Interventional
Source Imperial College London
Contact
Status Completed
Phase N/A
Start date April 2011
Completion date October 2013

See also
  Status Clinical Trial Phase
Recruiting NCT06104527 - Indicator Amino Acid Oxidation in ICU Patients N/A
Active, not recruiting NCT01624792 - Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2 N/A
Completed NCT02270502 - Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit N/A
Completed NCT02391103 - Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery N/A
Completed NCT05210205 - Physiological Response to Protein and Energy-enhanced Food Products During Winter Military Training N/A
Completed NCT01372176 - Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial Phase 4
Completed NCT04789031 - Muscle Status to Oral Nutritional Supplementation in Hemodialysis Patients With Protein Energy Wasting N/A
Completed NCT01355497 - Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum Phase 3
Completed NCT01355484 - Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) Phase 3
Enrolling by invitation NCT04582630 - Effects of Omega-3 Fatty Acids on Muscle Wasting
Completed NCT03560713 - Effects of Functional Electrical Stimulation in Patients Undergoing Coronary Artery Bypass Grafting Surgery N/A
Completed NCT03026985 - Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring ECMO N/A
Completed NCT02057094 - Effects of Protein Supplementation on Lean Body Mass Recovery From Extreme Military Training N/A
Completed NCT04698798 - Skeletal Muscle Wasting in SARS-CoV-2 N/A
Recruiting NCT06250686 - Exercise and Nutrition Intervention in Ovarian Cancer N/A
Completed NCT04744142 - Effects of Ketones on Muscle Wasting During Caloric Restriction in Lean Females N/A
Completed NCT06167772 - Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness N/A
Recruiting NCT04353063 - Muscle Wasting in Children and Adolescents With Cancer N/A
Completed NCT04266015 - Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery N/A
Recruiting NCT04889235 - Diaphragm Kinetics Following Hepatic Resection